IBT
MGNX icon

International Biotechnology Trust’s MacroGenics MGNX Stock Holding History

International Biotechnology Trust’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-19,000
Closed -$342K – 67
2019
Q1 		$342K Buy
+19,000
New +$328K 0.13% 62
2017
Q3 		– Sell
-54,000
Closed -$945K – 59
2017
Q2 		$945K Hold
54,000
– – 0.36% 51
2017
Q1 		$1M Hold
54,000
– – 0.38% 51
2016
Q4 		$1.1M Buy
+54,000
New +$1.36M 0.5% 37

Other funds holding MGNX

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

International Biotechnology Trust's MGNX Position: Q2 2019 in Review

International Biotechnology Trust sold out of MacroGenics (MGNX) in Q2 2019, closing a stake of 19,000 shares — an estimated $342K sold.

International Biotechnology Trust first reported a position in MGNX in Q4 2016 and held it in 4 quarters. The position peaked at $1.1M in Q4 2016. 130 funds tracked by Wall St. Rank hold MGNX as of Q2 2019.

  • International Biotechnology Trust reported no remaining MacroGenics position as of Q2 2019 after selling out during the quarter.
  • International Biotechnology Trust sold 19,000 MacroGenics shares in Q2 2019, an estimated $342K.
  • International Biotechnology Trust first reported a position in MacroGenics in Q4 2016 and held it in 4 quarters.
  • International Biotechnology Trust's MacroGenics position peaked at $1.1M in Q4 2016.
  • 130 funds tracked by Wall St. Rank held MacroGenics as of Q2 2019.

Based on International Biotechnology Trust's 13F filing for Q2 2019, filed 14 Aug 2019.